Chargement en cours...
Taming expectations of metformin as a treatment to extend healthspan
The anti-hyperglycemic medication metformin has potential to be the first drug tested to slow aging in humans. While the Targeting Aging with Metformin (TAME) proposal and other small-scale clinical trials have the potential to support aging as a treatment indication, we propose that the goals of th...
Enregistré dans:
| Publié dans: | GeroScience |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer International Publishing
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544683/ https://ncbi.nlm.nih.gov/pubmed/30746605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-019-00057-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|